(Q38299338)

1 September 2017

title

Interferon therapy in primary care (English)

1 reference

1 September 2017

J M. Piper

1

1 reference

1 September 2017

T T.-S. Wen

series ordinal

2

1 reference

1 September 2017

E M.-J. Xenakis

series ordinal

3

1 reference

1 September 2017

publication date

1 July 2001

1 reference

Primary care update for Ob/Gyns

1 September 2017

published in

1 reference

1 September 2017

volume

8

1 reference

1 September 2017

issue

4

1 reference

1 September 2017

page(s)

163-169

1 reference

Interferons alpha, beta and gamma therapy of anogenital human papillomavirus infections

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1068-607X%2800%2900082-2

7 January 2021

Interferons in dermatology. Present-day standard

1 reference

https://api.crossref.org/works/10.1016%2FS1068-607X%2800%2900082-2

7 January 2021

Chronic hepatitis B virus infection: treatment strategies for the next millennium

1 reference

https://api.crossref.org/works/10.1016%2FS1068-607X%2800%2900082-2

7 January 2021

Combination therapy with interferon and ribavirin in the treatment of chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1016%2FS1068-607X%2800%2900082-2

7 January 2021

New schedules of interferon for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1068-607X%2800%2900082-2

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS1068-607X%2800%2900082-2

7 January 2021

Immunologic therapy of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1068-607X%2800%2900082-2

7 January 2021

Disease-modifying drugs for relapsing-remitting multiple sclerosis and future directions for multiple sclerosis therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1068-607X%2800%2900082-2

7 January 2021

Therapeutic approaches to papillomavirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1068-607X%2800%2900082-2

7 January 2021

New approaches to the systemic treatment of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1068-607X%2800%2900082-2

7 January 2021

Treatment of malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1068-607X%2800%2900082-2

7 January 2021

Multiple myeloma: an update on biology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1068-607X%2800%2900082-2

7 January 2021

Essential thrombocythaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1068-607X%2800%2900082-2

7 January 2021

Interferon-alpha therapy in polycythemia vera and essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1016%2FS1068-607X%2800%2900082-2

7 January 2021

Keloids and hypertrophic scars: review and treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1068-607X%2800%2900082-2

7 January 2021

Managing side effects of interferon-beta in patients with relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1068-607X%2800%2900082-2

7 January 2021

Multiple sclerosis: side effects of interferon beta therapy and their management

1 reference

https://api.crossref.org/works/10.1016%2FS1068-607X%2800%2900082-2

7 January 2021

Interferon-alpha-associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1068-607X%2800%2900082-2

7 January 2021

Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review

1 reference

https://api.crossref.org/works/10.1016%2FS1068-607X%2800%2900082-2

7 January 2021

Case report of interferon alfa therapy for multiple myeloma during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1068-607X%2800%2900082-2

7 January 2021

10.1016/S1068-607X(00)00082-2

Identifiers

DOI

1 reference

1 September 2017

1 reference